other officer, employee or agent of the Food and Drug Administration to promulgate regulations or undertake and finalize rulemaking required under this Act that are not promulgated or published within the time frames set forth herein, or to provide the certification of designated State medical cannabis products within the time frames set forth herein, or to enjoin agency action. The exclusive venue for bringing any such action shall be the District Court for the District of Columbia. Upon demonstration of undue delay or failure to adhere strictly to statutory deadlines, or other violations of law and equity, equitable relief in the form of a writ of mandamus compelling action shall issue, among such other relief as the court may see fit. . 302. Certain department of health and human services and food and drug administration reporting requirements (a) In general Not later than one calendar year after the date of the enactment of this Act, and annually thereafter for the following five calendar years, the Secretary of Health and Human Services shall submit to the appropriate congressional committees, reports on the following: (1) Section 301 designated State medical cannabis products report A report detailing— (A) administrative actions taken pursuant to section 301 of this Act (and the amendments made by such section) to ensure certification of designated State medical cannabis products, including timelines and reasons for any delays past statutory deadlines